Todd A. Hembrough
EntreMed
Inc, 9640 Medical Center Dr
Rockville
USA
Name/email consistency: high
- Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. Hembrough, T.A., Ruiz, J.F., Swerdlow, B.M., Swartz, G.M., Hammers, H.J., Zhang, L., Plum, S.M., Williams, M.S., Strickland, D.K., Pribluda, V.S. Blood (2004)
- Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Hembrough, T.A., Swartz, G.M., Papathanassiu, A., Vlasuk, G.P., Rote, W.E., Green, S.J., Pribluda, V.S. Cancer Res. (2003)
- Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. Hembrough, T.A., Ruiz, J.F., Papathanassiu, A.E., Green, S.J., Strickland, D.K. J. Biol. Chem. (2001)